Hepatocellular carcinoma: what are the differential costs compared to the general population?
HCC-related hospital admissions impose a significantly higher economic burden due to the complexity of care. Given the high mortality and resource utilization, advancements in early detection, treatment, and cost-effective interventions are needed to improve patient outcomes and reduce healthcare costs.
Authors
- Josep Darbà (ORCID: https://orcid.org/0000-0003-2371-0999)
- Meritxell Ascanio
Institutions
- Health Economics and Outcomes Research (United Kingdom) (GB)
- Universitat de Barcelona (ES)
Publication Details
- Journal
- Journal of Medical Economics
- Published
- 2025-03-24
- DOI
- https://doi.org/10.1080/13696998.2025.2484073
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35